- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/36 - ExtractionSeparationPurification by a combination of two or more processes of different types
Patent holdings for IPC class C07K 1/36
Total number of patents in this class: 1130
10-year publication summary
|
84
|
64
|
63
|
83
|
87
|
99
|
116
|
86
|
83
|
59
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4362 |
66 |
| Genentech, Inc. | 4012 |
32 |
| EMD Millipore Corporation | 648 |
27 |
| Amgen Inc. | 4118 |
22 |
| Takeda Pharmaceutical Company Limited | 2706 |
19 |
| Plasma Technologies, LLC | 31 |
15 |
| Genzyme Corporation | 1297 |
14 |
| Bristol-myers Squibb Company | 4850 |
13 |
| Green Cross Corporation | 202 |
12 |
| AbbVie Biotechnology Ltd. | 174 |
11 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 293 |
10 |
| Sartorius Stedim Biotech GmbH | 840 |
9 |
| Abbvie Inc. | 1802 |
8 |
| The Catholic University of America | 99 |
8 |
| CSL Behring AG | 176 |
8 |
| Agency for Science, Technology and Research | 3659 |
7 |
| Ares Trading S.A. | 290 |
7 |
| Green Cross Holdings Corporation | 50 |
7 |
| Cytiva BioProcess R&D AB | 312 |
7 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| Other owners | 822 |